GenAssist, Inc.
PrivateLast Round
Grant
Aug 1, 2026
Total Funding Raised
$1.64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GenAssist, Inc. is a biotechnology company that develops regenerative biomaterials, including its flagship MyoMatrix™ scaffold, to restore skeletal muscle structure and function following traumatic injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenAssist, Inc. Comparables
Compare GenAssist, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sarcogenics | 86% | |
| Conexeu Sciences Inc. | 76% | |
| Spiderwort | 66% |
GenAssist, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2026 | ||||
| SAFE | Apr 17, 2026 | ||||
| Grant | Oct 28, 2025 | ||||
| Grant | May 1, 2023 |
GenAssist, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arch Grants | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 34% MoM.
- Aug 1, 2026
$1.25M grant awarded by the National Science Foundation.
GenAssist, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenAssist, Inc.'s valuation, stock price, and market status.
Is GenAssist, Inc. a public or private company?
GenAssist, Inc. is a private company.
What is the current stock price of GenAssist, Inc.?
GenAssist, Inc. is a private company with no public stock price. Caplight tracks GenAssist, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GenAssist, Inc. worth (valuation)?
Valuation information for GenAssist, Inc. is not publicly available.
Can I buy GenAssist, Inc. stock?
GenAssist, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenAssist, Inc.'s last funding round?
GenAssist, Inc.'s most recent funding round was Grant on August 1, 2026.
Who are the main investors in GenAssist, Inc.?
Key investors in GenAssist, Inc. include Arch Grants, National Science Foundation.
Will GenAssist, Inc. IPO soon?
No public IPO plans have been announced for GenAssist, Inc..
How can I track GenAssist, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenAssist, Inc.'s secondary market activity and sign up for updates.